Drug-induced thrombocytopenia secondary to natalizumab treatment

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Cachia, David ^a   Izzy, Saef ^b   Berriosmorales, Idanis ^c   Ionete, Carolina ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; METHYLPREDNISOLONE; NATALIZUMAB; PREDNISONE; RITUXIMAB; THROMBOCYTE ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD CYTOLOGY; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INFUSION RELATED REACTION; LYMPHOMA; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; NATALIZUMAB INDUCED THROMBOCYTOPENIA; PRIORITY JOURNAL; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84901934002     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-203313     Document Type: Article

References (9)

1. Rudick RA, Stuart WH, Calabresi PA, et al.; SENTINEL Investigators. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 2006;354:911-23.
2. Rieckmann P, O'Connor P, Francis G, et al. Hematological effects of interferon-β-1a (Rebif) therapy in multiple sclerosis. Drug Saf 2004;27:745-56. (Pubitemid 39158995)
3. Stosic M, De Jesus P, McCarthy J, et al. Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology 2011;77:505-7.
4. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-7. (Pubitemid 47236283)
5. Braendstrup P, Bjerrum OW, Nielsen OJ. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 2005;78:275-80. (Pubitemid 40471119)
6. Medeot M, Zaja F, Vianelli N, et al. Rituximab therapy in adult patients with relapsed or refractory ITP: long term follow-up results. Eur J Haematol 2008;81:165-9.
7. Hauser SL, Waubant E, Arnold DL, et al.; HERMES Trial Group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008;358:676-88. (Pubitemid 351240747)
8. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008;37:95-403.
9. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007;357:2237-47. (Pubitemid 350190754)